TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expression
TGF-β 活化激酶 1 抑制剂 LL-Z1640-2 通过抑制 NLRP3 炎症小体、TACE、TNF-α 和 RANKL 表达,减少类风湿关节炎小鼠模型中的关节炎症和骨质破坏
期刊:Clinical & Translational Immunology
影响因子:4.6
doi:10.1002/cti2.1371
Hirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, Masahiro Hiasa, Yusuke Inoue, Asuka Oda, Kotaro Tanimoto, So Shimizu, Yoshiki Higa, Takeshi Harada, Masahiro Oura, Kimiko Sogabe, Tomoyo Hara, Ryohei Sumitani, Tomoko Maruhashi, Mayu Sebe, Rie Tsutsumi, Hiroshi Sakaue, Itsuro Endo, Toshio Matsumot